Revolution Medicines · 1 week ago
Associate Director, Global Pricing Strategy & Analytics
United States
Full-time
Remote
Senior Level, Lead/Staff, Director/Executive
$177K/yr - $221K/yr
6+ years expRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Associate Director, Global Pricing Strategy & Analytics will be responsible for shaping and executing global pricing strategies, collaborating with cross-functional teams to ensure alignment with business objectives and market dynamics.
HealthcareLife ScienceHealth CareMedical
Responsibilities
Support the development and execution of global pricing strategies for pipeline products across key markets
Establish pricing guidance, guardrails, and launch sequencing strategies to optimize global value
Evaluate pricing scenarios considering payer dynamics, competitive landscape, and regulatory constraints
Support early asset strategy by integrating pricing considerations into clinical and commercial planning
Design and deliver advanced pricing and access analytics, including price-volume trade-offs, corridor analyses, and international reference pricing (IRP) impact
Develop and maintain pricing models to inform decision-making at global and regional levels
Generate insights from real-world data, market research, and analog products to support pricing decisions
Monitor pricing performance and identify risks/opportunities post-launch
Drive pricing governance processes, including global price approvals and exception management
Ensure compliance with global pricing policies and external regulations
Partner with regional and country teams to support local price setting and negotiations
Collaborate closely with Market Access, HEOR, Commercial, Finance, and Legal teams
Align pricing strategies with value proposition, evidence generation, and reimbursement pathways
Provide strategic input into business development opportunities, including licensing and acquisitions
Develop global pricing infrastructure including systems, tools, and analytical platforms
Contribute to the development of pricing frameworks, dashboards, and best practices
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MPH, PhD, PharmD, or equivalent) preferred
6+ years of experience in pharmaceutical/biotech industry, with strong focus on pricing, market access, or commercial analytics
Deep understanding of global pricing, reimbursement systems, and payer dynamics
Strong analytical and quantitative skills with experience in pricing modeling and data analysis
Ability to translate complex data into clear strategic recommendations
Excellent communication and stakeholder management skills
Proven ability to work cross-functionally in a global, matrixed environment
High level of business acumen and strategic thinking
Preferred
Experience in global pricing strategy and launch pricing preferred
Experience with oncology or specialty therapeutics
Familiarity with international reference pricing (IRP), health technology assessment (HTA), and access pathways
Experience supporting pipeline assets and early commercialization strategy
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Some positions may include eligibility to earn commissions/bonus based on company and/or individual performance
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
1001-5000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
3%
Represents job field similar to this job
Accounting and Finance
Engineering and Development
Legal and Compliance
Management and Executive
Customer Service and Support
Trends of Total Sponsorships
*2026 (11)
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2026-04-15Post Ipo Equity· $1.5B
2026-04-15Post Ipo Debt· $500M
2025-06-24Post Ipo Debt· $250M
Leadership Team
Neil MacGregor
SVP JPAC
Martin Voelkl
Vice President, General Manager Germany
Recent News
2026-07-10
The Motley Fool
2026-07-10
South China Morning Post
2026-07-08
Company data provided by crunchbase